Safety of oxygen supplementation for infectious disease : an open-label , randomized , controlled pilot study

Safety of oxygen supplementation for infectious disease : an open-label , randomized , controlled pilot study - Safety of oxygen supplementation for infectious disease : an open-label , randomized , controlled pilot study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036082

Enrollment

Registered

2019-03-05

Start date

2019-02-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection diseases

Interventions

Oxygen therapy to maintain SpO2 &gt

=95% Follow-up(SpO2 &gt

=90%)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)20 years and older 2)Signed informed consent 3)Do not home oxygen therapy user

Exclusion criteria

Exclusion criteria: 1)Not signed informed consent 2)Severe concomitant disease (Dialysis,cancer-carrying patient) 3)Pregnancy, breastfeeding 4)Home oxygen therapy user 5)Chronic type2 respiratory failure

Design outcomes

Primary

Measure	Time frame
hospital discharge outcomes (mortality,transfer to acute care hospitals,transfer to chronic care hospitals or nursing homes)	—

Countries

Japan

Contacts

Public ContactToshikazu Abe

Juntendo University Hospital Department of General Medicine

to-abe@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026